{
    "abstract": "Following publication of results from two phase-3 clinical trials in 10 countries or territories, endemic countries began licensing the first dengue vaccine in 2015. Using a published mathematical model, we evaluated the cost-effectiveness of dengue vaccination in populations similar to those at the trial sites in those same Latin American and Asian countries. Our main scenarios (30-year horizon, 80% coverage) entailed 3-dose routine vaccinations costing US$20/dose beginning at age 9, potentially supplemented by catch-up programs of 4- or 8-year cohorts. We obtained illness costs per case, dengue mortality, vaccine wastage, and vaccine administration costs from the literature. We estimated that routine vaccination would reduce yearly direct and indirect illness cost per capita by 22% (from US$10.51 to US$8.17) in the Latin American countries and by 23% (from US$5.78 to US$4.44) in the Asian countries. Using a health system perspective, the incremental cost-effectiveness ratio (ICER) averaged US$4,216/disability-adjusted life year (DALY) averted in the five Latin American countries (range: US$666/DALY in Puerto Rico to US$5,865/DALY in Mexico). In the five Asian countries, the ICER averaged US$3,751/DALY (range: US$1,935/DALY in Malaysia to US$5,101/DALY in the Philippines). From a health system perspective, the vaccine proved to be highly cost effective (ICER under one times the per capita GDP) in seven countries and cost effective (ICER 1\u20133 times the per capita GDP) in the remaining three countries. From a societal perspective, routine vaccination proved cost-saving in three countries. Including catch-up campaigns gave similar ICERs. Thus, this vaccine could have a favorable economic value in sites similar to those in the trials.",
    "author_highlights": [
        {
            "endOffset": 13462,
            "sentence": "Routine vaccination at age 9 would avert 22\u201323% of dengue illness costs.",
            "startOffset": 13390
        },
        {
            "endOffset": 13544,
            "sentence": "Cost-effectiveness ratios averaged $4216/DALY in Latin America and $3751 in Asia.",
            "startOffset": 13463
        },
        {
            "endOffset": 13628,
            "sentence": "From a societal perspective, vaccination would be cost saving in 3 of the 10 sites.",
            "startOffset": 13545
        },
        {
            "endOffset": 13713,
            "sentence": "Vaccination would be cost effective or highly cost effective in all remaining sites.",
            "startOffset": 13629
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Samir",
                    "initial": "S.",
                    "last": "Bhatt"
                },
                {
                    "first": "Peter W.",
                    "initial": "P.W.",
                    "last": "Gething"
                },
                {
                    "first": "Oliver J.",
                    "initial": "O.J.",
                    "last": "Brady"
                },
                {
                    "first": "Jane P.",
                    "initial": "J.P.",
                    "last": "Messina"
                },
                {
                    "first": "Andrew W.",
                    "initial": "A.W.",
                    "last": "Farlow"
                },
                {
                    "first": "Catherine L.",
                    "initial": "C.L.",
                    "last": "Moyes"
                },
                {
                    "first": "John M.",
                    "initial": "J.M.",
                    "last": "Drake"
                },
                {
                    "first": "John S.",
                    "initial": "J.S.",
                    "last": "Brownstein"
                },
                {
                    "first": "Anne G.",
                    "initial": "A.G.",
                    "last": "Hoen"
                },
                {
                    "first": "Osman",
                    "initial": "O.",
                    "last": "Sankoh"
                },
                {
                    "first": "Monica F.",
                    "initial": "M.F.",
                    "last": "Myers"
                },
                {
                    "first": "Dylan B.",
                    "initial": "D.B.",
                    "last": "George"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Jaenisch"
                },
                {
                    "first": "G. R.",
                    "initial": "G.R.",
                    "last": "William Wint"
                },
                {
                    "first": "Cameron P.",
                    "initial": "C.P.",
                    "last": "Simmons"
                },
                {
                    "first": "Thomas W.",
                    "initial": "T.W.",
                    "last": "Scott"
                },
                {
                    "first": "Jeremy J.",
                    "initial": "J.J.",
                    "last": "Farrar"
                },
                {
                    "first": "Simon I.",
                    "initial": "S.I.",
                    "last": "Hay"
                }
            ],
            "doi": "10.1038/nature12060",
            "firstpage": "504",
            "issn": "00280836",
            "lastpage": "507",
            "pmid": "23563266",
            "pub_year": 2013,
            "title": "The global distribution and burden of dengue",
            "volume": "496"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Cameron P.",
                    "initial": "C.P.",
                    "last": "Simmons"
                },
                {
                    "first": "Jeremy J.",
                    "initial": "J.J.",
                    "last": "Farrar"
                },
                {
                    "first": "Nguyen",
                    "initial": "N.",
                    "last": "Van Vinh Chau"
                },
                {
                    "first": "Bridget",
                    "initial": "B.",
                    "last": "Wills"
                }
            ],
            "doi": "10.1056/NEJMra1110265",
            "firstpage": "1423",
            "issn": "00284793",
            "lastpage": "1432",
            "pmid": "22494122",
            "pub_year": 2012,
            "title": "Current concepts: Dengue",
            "volume": "366"
        },
        "b0015": null,
        "b0020": {
            "authors": [
                {
                    "first": "Jeffrey D.",
                    "initial": "J.D.",
                    "last": "Stanaway"
                },
                {
                    "first": "Donald S.",
                    "initial": "D.S.",
                    "last": "Shepard"
                },
                {
                    "first": "Eduardo A.",
                    "initial": "E.A.",
                    "last": "Undurraga"
                },
                {
                    "first": "Yara A.",
                    "initial": "Y.A.",
                    "last": "Halasa"
                },
                {
                    "first": "Luc E.",
                    "initial": "L.E.",
                    "last": "Coffeng"
                },
                {
                    "first": "Oliver J.",
                    "initial": "O.J.",
                    "last": "Brady"
                },
                {
                    "first": "Simon I.",
                    "initial": "S.I.",
                    "last": "Hay"
                },
                {
                    "first": "Neeraj",
                    "initial": "N.",
                    "last": "Bedi"
                },
                {
                    "first": "Isabela M.",
                    "initial": "I.M.",
                    "last": "Bensenor"
                },
                {
                    "first": "Carlos A.",
                    "initial": "C.A.",
                    "last": "Casta\u00f1eda-Orjuela"
                },
                {
                    "first": "Ting Wu",
                    "initial": "T.W.",
                    "last": "Chuang"
                },
                {
                    "first": "Katherine B.",
                    "initial": "K.B.",
                    "last": "Gibney"
                },
                {
                    "first": "Ziad A.",
                    "initial": "Z.A.",
                    "last": "Memish"
                },
                {
                    "first": "Anwar",
                    "initial": "A.",
                    "last": "Rafay"
                },
                {
                    "first": "Kingsley N.",
                    "initial": "K.N.",
                    "last": "Ukwaja"
                },
                {
                    "first": "Naohiro",
                    "initial": "N.",
                    "last": "Yonemoto"
                },
                {
                    "first": "Christopher J.L.",
                    "initial": "C.J.L.",
                    "last": "Murray"
                }
            ],
            "doi": "10.1016/S1473-3099(16)00026-8",
            "firstpage": "712",
            "issn": "14733099",
            "lastpage": "723",
            "pmid": "26874619",
            "pub_year": 2016,
            "title": "The global burden of dengue: an analysis from the Global Burden of Disease Study 2013",
            "volume": "16"
        },
        "b0025": null,
        "b0030": null,
        "b0035": null,
        "b0040": {
            "authors": [
                {
                    "first": "Bruce Y.",
                    "initial": "B.Y.",
                    "last": "Lee"
                },
                {
                    "first": "Diana L.",
                    "initial": "D.L.",
                    "last": "Connor"
                },
                {
                    "first": "Sarah B.",
                    "initial": "S.B.",
                    "last": "Kitchen"
                },
                {
                    "first": "Kristina M.",
                    "initial": "K.M.",
                    "last": "Bacon"
                },
                {
                    "first": "Mirat",
                    "initial": "M.",
                    "last": "Shah"
                },
                {
                    "first": "Shawn T.",
                    "initial": "S.T.",
                    "last": "Brown"
                },
                {
                    "first": "Rachel R.",
                    "initial": "R.R.",
                    "last": "Bailey"
                },
                {
                    "first": "Yongjua",
                    "initial": "Y.",
                    "last": "Laosiritaworn"
                },
                {
                    "first": "Donald S.",
                    "initial": "D.S.",
                    "last": "Burke"
                },
                {
                    "first": "Derek A.T.",
                    "initial": "D.A.T.",
                    "last": "Cummings"
                }
            ],
            "doi": "10.4269/ajtmh.2011.10-0624",
            "firstpage": "764",
            "issn": "00029637",
            "lastpage": "772",
            "pmid": "21540387",
            "pub_year": 2011,
            "title": "Economic value of dengue vaccine in Thailand",
            "volume": "84"
        },
        "b0045": null,
        "b0050": {
            "authors": [
                {
                    "first": "Donald S.",
                    "initial": "D.S.",
                    "last": "Shepard"
                },
                {
                    "first": "Jose A.",
                    "initial": "J.A.",
                    "last": "Suaya"
                },
                {
                    "first": "Scott B.",
                    "initial": "S.B.",
                    "last": "Halstead"
                },
                {
                    "first": "Michael B.",
                    "initial": "M.B.",
                    "last": "Nathan"
                },
                {
                    "first": "Duane J.",
                    "initial": "D.J.",
                    "last": "Gubler"
                },
                {
                    "first": "Richard T.",
                    "initial": "R.T.",
                    "last": "Mahoney"
                },
                {
                    "first": "Daniel N.C.",
                    "initial": "D.N.C.",
                    "last": "Wang"
                },
                {
                    "first": "Martin I.",
                    "initial": "M.I.",
                    "last": "Meltzer"
                }
            ],
            "doi": "10.1016/j.vaccine.2003.09.019",
            "firstpage": "1275",
            "issn": "0264410X",
            "lastpage": "1280",
            "pmid": "15003657",
            "pub_year": 2004,
            "title": "Cost-effectiveness of a pediatric dengue vaccine",
            "volume": "22"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Eunha",
                    "initial": "E.",
                    "last": "Shim"
                }
            ],
            "doi": "10.1371/journal.pone.0175020",
            "issn": "19326203",
            "pmid": "28380060",
            "pub_year": 2017,
            "title": "Cost-effectiveness of dengue vaccination in Yucat\u00e1n, Mexico using a dynamic dengue transmission model",
            "volume": "12"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Eunha",
                    "initial": "E.",
                    "last": "Shim"
                }
            ],
            "doi": "10.4269/ajtmh.16-0810",
            "firstpage": "1227",
            "issn": "00029637",
            "lastpage": "1234",
            "pmid": "28500811",
            "pub_year": 2017,
            "title": "Cost-effectiveness of dengue vaccination programs in Brazil",
            "volume": "96"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Asrul Akmal",
                    "initial": "A.A.",
                    "last": "Shafie"
                },
                {
                    "first": "Hui Yee",
                    "initial": "H.Y.",
                    "last": "Yeo"
                },
                {
                    "first": "Laurent",
                    "initial": "L.",
                    "last": "Coudeville"
                },
                {
                    "first": "Lucas",
                    "initial": "L.",
                    "last": "Steinberg"
                },
                {
                    "first": "Balvinder Singh",
                    "initial": "B.S.",
                    "last": "Gill"
                },
                {
                    "first": "Rohani",
                    "initial": "R.",
                    "last": "Jahis"
                },
                {
                    "first": "H. S.S.",
                    "initial": "H.S.S.",
                    "last": "Amar-Singh"
                }
            ],
            "doi": "10.1007/s40273-017-0487-3",
            "firstpage": "575",
            "issn": "11707690",
            "lastpage": "589",
            "pmid": "28205150",
            "pub_year": 2017,
            "title": "The Potential Cost Effectiveness of Different Dengue Vaccination Programmes in Malaysia: A Value-Based Pricing Assessment Using Dynamic Transmission Mathematical Modelling",
            "volume": "35"
        },
        "b0070": {
            "authors": [
                {
                    "first": "S. R.",
                    "initial": "S.R.",
                    "last": "Hadinegoro"
                },
                {
                    "first": "J. L.",
                    "initial": "J.L.",
                    "last": "Arredondo-Garc\u00eda"
                },
                {
                    "first": "M. R.",
                    "initial": "M.R.",
                    "last": "Capeding"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Deseda"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Chotpitayasunondh"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Dietze"
                },
                {
                    "first": "H. I.",
                    "initial": "H.I.",
                    "last": "Hj Muhammad Ismail"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Reynales"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Limkittikul"
                },
                {
                    "first": "D. M.",
                    "initial": "D.M.",
                    "last": "Rivera-Medina"
                },
                {
                    "first": "H. N.",
                    "initial": "H.N.",
                    "last": "Tran"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Bouckenooghe"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Chansinghakul"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Cort\u00e9s"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Fanouillere"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Forrat"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Frago"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Gailhardou"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Jackson"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Noriega"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Plennevaux"
                },
                {
                    "first": "T. A.",
                    "initial": "T.A.",
                    "last": "Wartel"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Zambrano"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Saville"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1056/NEJMoa1506223",
            "firstpage": "1195",
            "issn": "00284793",
            "lastpage": "1206",
            "pmid": "26214039",
            "pub_year": 2015,
            "title": "Efficacy and long-term safety of a dengue vaccine in regions of endemic disease",
            "volume": "373"
        },
        "b0075": null,
        "b0080": null,
        "b0085": {
            "authors": [
                {
                    "first": "Eunha",
                    "initial": "E.",
                    "last": "Shim"
                }
            ],
            "doi": "10.4269/ajtmh.16-0194",
            "firstpage": "1137",
            "issn": "00029637",
            "lastpage": "1147",
            "pmid": "27601519",
            "pub_year": 2016,
            "title": "Dengue dynamics and vaccine cost-effectiveness analysis in the philippines",
            "volume": "95"
        },
        "b0090": null,
        "b0095": null,
        "b0100": null,
        "b0105": null,
        "b0110": null,
        "b0115": {
            "authors": [
                {
                    "first": "Donald S.",
                    "initial": "D.S.",
                    "last": "Shepard"
                },
                {
                    "first": "Eduardo A.",
                    "initial": "E.A.",
                    "last": "Undurraga"
                },
                {
                    "first": "Yara A.",
                    "initial": "Y.A.",
                    "last": "Halasa"
                },
                {
                    "first": "Jeffrey D.",
                    "initial": "J.D.",
                    "last": "Stanaway"
                }
            ],
            "doi": "10.1016/S1473-3099(16)00146-8",
            "firstpage": "935",
            "issn": "14733099",
            "lastpage": "941",
            "pmid": "27091092",
            "pub_year": 2016,
            "title": "The global economic burden of dengue: a systematic analysis",
            "volume": "16"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Maria Rosario",
                    "initial": "M.R.",
                    "last": "Capeding"
                },
                {
                    "first": "Ngoc Huu",
                    "initial": "N.H.",
                    "last": "Tran"
                },
                {
                    "first": "Sri Rezeki S.",
                    "initial": "S.R.S.",
                    "last": "Hadinegoro"
                },
                {
                    "first": "Hussain Imam Hj Muhammad",
                    "initial": "H.I.H.M.",
                    "last": "Ismail"
                },
                {
                    "first": "Tawee",
                    "initial": "T.",
                    "last": "Chotpitayasunondh"
                },
                {
                    "first": "Mary Noreen",
                    "initial": "M.N.",
                    "last": "Chua"
                },
                {
                    "first": "Chan Quang",
                    "initial": "C.Q.",
                    "last": "Luong"
                },
                {
                    "first": "Kusnandi",
                    "initial": "K.",
                    "last": "Rusmil"
                },
                {
                    "first": "Dewa Nyoman",
                    "initial": "D.N.",
                    "last": "Wirawan"
                },
                {
                    "first": "Revathy",
                    "initial": "R.",
                    "last": "Nallusamy"
                },
                {
                    "first": "Punnee",
                    "initial": "P.",
                    "last": "Pitisuttithum"
                },
                {
                    "first": "Usa",
                    "initial": "U.",
                    "last": "Thisyakorn"
                },
                {
                    "first": "In Kyu",
                    "initial": "I.K.",
                    "last": "Yoon"
                },
                {
                    "first": "Diane",
                    "initial": "D.",
                    "last": "Van Der Vliet"
                },
                {
                    "first": "Edith",
                    "initial": "E.",
                    "last": "Langevin"
                },
                {
                    "first": "Thelma",
                    "initial": "T.",
                    "last": "Laot"
                },
                {
                    "first": "Yanee",
                    "initial": "Y.",
                    "last": "Hutagalung"
                },
                {
                    "first": "Carina",
                    "initial": "C.",
                    "last": "Frago"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Boaz"
                },
                {
                    "first": "T. Anh",
                    "initial": "T.A.",
                    "last": "Wartel"
                },
                {
                    "first": "Nadia G.",
                    "initial": "N.G.",
                    "last": "Tornieporth"
                },
                {
                    "first": "Melanie",
                    "initial": "M.",
                    "last": "Saville"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Bouckenooghe"
                }
            ],
            "doi": "10.1016/S0140-6736(14)61060-6",
            "firstpage": "1358",
            "issn": "01406736",
            "lastpage": "1365",
            "pmid": "25018116",
            "pub_year": 2014,
            "title": "Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: A phase 3, randomised, observer-masked, placebo-controlled trial",
            "volume": "384"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Luis",
                    "initial": "L.",
                    "last": "Villar"
                },
                {
                    "first": "Gustavo Horacio",
                    "initial": "G.H.",
                    "last": "Dayan"
                },
                {
                    "first": "Jos\u00e9 Luis",
                    "initial": "J.L.",
                    "last": "Arredondo-Garc\u00eda"
                },
                {
                    "first": "Doris Maribel",
                    "initial": "D.M.",
                    "last": "Rivera"
                },
                {
                    "first": "Rivaldo",
                    "initial": "R.",
                    "last": "Cunha"
                },
                {
                    "first": "Carmen",
                    "initial": "C.",
                    "last": "Deseda"
                },
                {
                    "first": "Humberto",
                    "initial": "H.",
                    "last": "Reynales"
                },
                {
                    "first": "Maria Selma",
                    "initial": "M.S.",
                    "last": "Costa"
                },
                {
                    "first": "Javier Osvaldo",
                    "initial": "J.O.",
                    "last": "Morales-Ram\u00edrez"
                },
                {
                    "first": "Gabriel",
                    "initial": "G.",
                    "last": "Carrasquilla"
                },
                {
                    "first": "Luis Carlos",
                    "initial": "L.C.",
                    "last": "Rey"
                },
                {
                    "first": "Reynaldo",
                    "initial": "R.",
                    "last": "Dietze"
                },
                {
                    "first": "Kleber",
                    "initial": "K.",
                    "last": "Luz"
                },
                {
                    "first": "Enrique",
                    "initial": "E.",
                    "last": "Rivas"
                },
                {
                    "first": "Maria Consuelo Miranda",
                    "initial": "M.C.M.",
                    "last": "Montoya"
                },
                {
                    "first": "Margarita Cort\u00e9s",
                    "initial": "M.C.",
                    "last": "Supelano"
                },
                {
                    "first": "Betzana",
                    "initial": "B.",
                    "last": "Zambrano"
                },
                {
                    "first": "Edith",
                    "initial": "E.",
                    "last": "Langevin"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Boaz"
                },
                {
                    "first": "Nadia",
                    "initial": "N.",
                    "last": "Tornieporth"
                },
                {
                    "first": "Melanie",
                    "initial": "M.",
                    "last": "Saville"
                },
                {
                    "first": "Fernando",
                    "initial": "F.",
                    "last": "Noriega"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1056/NEJMoa1411037",
            "firstpage": "113",
            "issn": "00284793",
            "lastpage": "123",
            "pmid": "25365753",
            "pub_year": 2015,
            "title": "Efficacy of a tetravalent dengue vaccine in children in Latin America",
            "volume": "372"
        },
        "b0130": null,
        "b0135": null,
        "b0140": null,
        "b0145": {
            "authors": [
                {
                    "first": "Changik",
                    "initial": "C.",
                    "last": "Jo"
                }
            ],
            "doi": "10.3350/cmh.2014.20.4.327",
            "firstpage": "327",
            "issn": "2287285X",
            "lastpage": "337",
            "pmid": "25548737",
            "pub_year": 2014,
            "title": "Cost-of-illness studies: concepts, scopes, and methods",
            "volume": "20"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Joshua A.",
                    "initial": "J.A.",
                    "last": "Salomon"
                },
                {
                    "first": "Haidong",
                    "initial": "H.",
                    "last": "Wang"
                },
                {
                    "first": "Michael K.",
                    "initial": "M.K.",
                    "last": "Freeman"
                },
                {
                    "first": "Theo",
                    "initial": "T.",
                    "last": "Vos"
                },
                {
                    "first": "Abraham D.",
                    "initial": "A.D.",
                    "last": "Flaxman"
                },
                {
                    "first": "Alan D.",
                    "initial": "A.D.",
                    "last": "Lopez"
                },
                {
                    "first": "Christopher J.L.",
                    "initial": "C.J.L.",
                    "last": "Murray"
                }
            ],
            "doi": "10.1016/S0140-6736(12)61690-0",
            "firstpage": "2144",
            "issn": "01406736",
            "lastpage": "2162",
            "pmid": "23245606",
            "pub_year": 2012,
            "title": "Healthy life expectancy for 187 countries, 1990-2010: A systematic analysis for the Global Burden Disease Study 2010",
            "volume": "380"
        },
        "b0155": null,
        "b0160": null,
        "b0165": null,
        "b0170": null,
        "b0175": {
            "authors": [
                {
                    "first": "Ma\u00efna",
                    "initial": "M.",
                    "last": "L'Azou"
                },
                {
                    "first": "Annick",
                    "initial": "A.",
                    "last": "Moureau"
                },
                {
                    "first": "Elsa",
                    "initial": "E.",
                    "last": "Sarti"
                },
                {
                    "first": "Joshua",
                    "initial": "J.",
                    "last": "Nealon"
                },
                {
                    "first": "Betzana",
                    "initial": "B.",
                    "last": "Zambrano"
                },
                {
                    "first": "T. Anh",
                    "initial": "T.A.",
                    "last": "Wartel"
                },
                {
                    "first": "Luis",
                    "initial": "L.",
                    "last": "Villar"
                },
                {
                    "first": "Maria R.Z.",
                    "initial": "M.R.Z.",
                    "last": "Capeding"
                },
                {
                    "first": "R. Leon",
                    "initial": "R.L.",
                    "last": "Ochiai"
                }
            ],
            "doi": "10.1056/NEJMoa1503877",
            "firstpage": "1155",
            "issn": "00284793",
            "lastpage": "1166",
            "pmid": "27007959",
            "pub_year": 2016,
            "title": "Symptomatic dengue in children in 10 Asian and Latin American countries",
            "volume": "374"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Elsa",
                    "initial": "E.",
                    "last": "Sarti"
                },
                {
                    "first": "Ma\u00efna",
                    "initial": "M.",
                    "last": "L'Azou"
                },
                {
                    "first": "Marcela",
                    "initial": "M.",
                    "last": "Mercado"
                },
                {
                    "first": "Pablo",
                    "initial": "P.",
                    "last": "Kuri"
                },
                {
                    "first": "Joao Bosco",
                    "initial": "J.B.",
                    "last": "Siqueira"
                },
                {
                    "first": "Erick",
                    "initial": "E.",
                    "last": "Solis"
                },
                {
                    "first": "Fernando",
                    "initial": "F.",
                    "last": "Noriega"
                },
                {
                    "first": "R. Leon",
                    "initial": "R.L.",
                    "last": "Ochiai"
                }
            ],
            "doi": "10.1016/j.ijid.2016.01.015",
            "firstpage": "44",
            "issn": "12019712",
            "lastpage": "49",
            "pmid": "26836763",
            "pub_year": 2016,
            "title": "A comparative study on active and passive epidemiological surveillance for dengue in five countries of Latin America",
            "volume": "44"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Neil M.",
                    "initial": "N.M.",
                    "last": "Ferguson"
                },
                {
                    "first": "Isabel",
                    "initial": "I.",
                    "last": "Rodr\u00edguez-Barraquer"
                },
                {
                    "first": "Ilaria",
                    "initial": "I.",
                    "last": "Dorigatti"
                },
                {
                    "first": "Luis",
                    "initial": "L.",
                    "last": "Mier-Y-Teran-Romero"
                },
                {
                    "first": "Daniel J.",
                    "initial": "D.J.",
                    "last": "Laydon"
                },
                {
                    "first": "Derek A.T.",
                    "initial": "D.A.T.",
                    "last": "Cummings"
                }
            ],
            "doi": "10.1126/science.aaf9590",
            "firstpage": "1033",
            "issn": "00368075",
            "lastpage": "1036",
            "pmid": "27701113",
            "pub_year": 2016,
            "title": "Benefits and risks of the sanofi-pasteur dengue vaccine: Modeling optimal deployment",
            "volume": "353"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Gustavo",
                    "initial": "G.",
                    "last": "Olivera-Botello"
                },
                {
                    "first": "Laurent",
                    "initial": "L.",
                    "last": "Coudeville"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Fanouillere"
                },
                {
                    "first": "Bruno",
                    "initial": "B.",
                    "last": "Guy"
                },
                {
                    "first": "Laurent",
                    "initial": "L.",
                    "last": "Chambonneau"
                },
                {
                    "first": "Fernando",
                    "initial": "F.",
                    "last": "Noriega"
                },
                {
                    "first": "Nicholas",
                    "initial": "N.",
                    "last": "Jackson"
                },
                {
                    "first": "Jos\u00e9 Luis",
                    "initial": "J.L.",
                    "last": "Arredondo-Garc\u00eda"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Bouckenooghe"
                },
                {
                    "first": "Maria Rosario",
                    "initial": "M.R.",
                    "last": "Capeding"
                },
                {
                    "first": "Tawee",
                    "initial": "T.",
                    "last": "Chotpitayasunondh"
                },
                {
                    "first": "Mary Noreen",
                    "initial": "M.N.",
                    "last": "Chua"
                },
                {
                    "first": "Margarita Cort\u00e9s",
                    "initial": "M.C.",
                    "last": "Supelano"
                },
                {
                    "first": "Carmen",
                    "initial": "C.",
                    "last": "Deseda"
                },
                {
                    "first": "Reynaldo",
                    "initial": "R.",
                    "last": "Dietze"
                },
                {
                    "first": "Carina",
                    "initial": "C.",
                    "last": "Frago"
                },
                {
                    "first": "Sri Rezeki S.",
                    "initial": "S.R.S.",
                    "last": "Hadinegoro"
                },
                {
                    "first": "Chan Quang",
                    "initial": "C.Q.",
                    "last": "Luong"
                },
                {
                    "first": "Hussain Imam Hj",
                    "initial": "H.I.H.",
                    "last": "Muhammad Ismail"
                },
                {
                    "first": "Revathy",
                    "initial": "R.",
                    "last": "Nallusamy"
                },
                {
                    "first": "Punnee",
                    "initial": "P.",
                    "last": "Pitisuttithum"
                },
                {
                    "first": "Humberto",
                    "initial": "H.",
                    "last": "Reynales"
                },
                {
                    "first": "Doris Maribel",
                    "initial": "D.M.",
                    "last": "Rivera-Medina"
                },
                {
                    "first": "Kusnandi",
                    "initial": "K.",
                    "last": "Rusmil"
                },
                {
                    "first": "Usa",
                    "initial": "U.",
                    "last": "Thisyakorn"
                },
                {
                    "first": "Ngoc Huu",
                    "initial": "N.H.",
                    "last": "Tran"
                },
                {
                    "first": "T. Anh",
                    "initial": "T.A.",
                    "last": "Wartel"
                },
                {
                    "first": "Dewa Nyoman",
                    "initial": "D.N.",
                    "last": "Wirawan"
                },
                {
                    "first": "In Kyu",
                    "initial": "I.K.",
                    "last": "Yoon"
                },
                {
                    "first": "Betzana",
                    "initial": "B.",
                    "last": "Zambrano"
                }
            ],
            "doi": "10.1093/infdis/jiw297",
            "firstpage": "994",
            "issn": "00221899",
            "lastpage": "1000",
            "pmid": "27418050",
            "pub_year": 2016,
            "title": "Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America",
            "volume": "214"
        },
        "b0195": {
            "authors": [
                {
                    "first": "U.",
                    "initial": "U.",
                    "last": "Thavara"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Tawatsin"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Nagao"
                }
            ],
            "doi": "10.1017/S0950268813001866",
            "firstpage": "1245",
            "issn": "09502688",
            "lastpage": "1258",
            "pmid": "23925059",
            "pub_year": 2014,
            "title": "Simulations to compare efficacies of tetravalent dengue vaccines and mosquito vector control",
            "volume": "142"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Melanie Y.",
                    "initial": "M.Y.",
                    "last": "Bertram"
                },
                {
                    "first": "Jeremy A.",
                    "initial": "J.A.",
                    "last": "Lauer"
                },
                {
                    "first": "Kees",
                    "initial": "K.",
                    "last": "De Joncheere"
                },
                {
                    "first": "Tessa",
                    "initial": "T.",
                    "last": "Edejer"
                },
                {
                    "first": "Raymond",
                    "initial": "R.",
                    "last": "Hutubessy"
                },
                {
                    "first": "Marie Paule",
                    "initial": "M.P.",
                    "last": "Kieny"
                },
                {
                    "first": "Suzanne R.",
                    "initial": "S.R.",
                    "last": "Hill"
                }
            ],
            "doi": "10.2471/BLT.15.164418",
            "firstpage": "925",
            "issn": "00429686",
            "lastpage": "930",
            "pmid": "27994285",
            "pub_year": 2016,
            "title": "Cost-effectiveness thresholds: Pros and cons",
            "volume": "94"
        }
    },
    "body_text": [
        {
            "endOffset": 26297,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "We estimated that R9 alone reduced the incidence of symptomatic dengue episodes over 30 years by an average of 23.1% in the five Latin American countries, dropping by 249 (from 1079) per 100,000 population.",
            "startOffset": 26091,
            "title": "Effectiveness"
        },
        {
            "endOffset": 19690,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 19689,
                    "startOffset": 19682
                },
                "b0125": {
                    "endOffset": 19689,
                    "startOffset": 19682
                }
            },
            "secId": "s0020",
            "sentence": "This cost-effectiveness analysis of dengue vaccination was conducted from both health system and societal perspectives for sites in the 10 countries where clinical trials for the licensed dengue vaccine were conducted [24,25].",
            "startOffset": 19464,
            "title": "Overview"
        },
        {
            "endOffset": 28418,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Table 3 shows the illness costs per capita under the no-vaccination and the three-vaccination strategies.",
            "startOffset": 28313,
            "title": "Costs"
        },
        {
            "endOffset": 31248,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Three countries (Brazil, Malaysia, and Puerto Rico) would obtain cost savings, indicating that the costs of a vaccine would be offset by savings in treatment and productivity losses from fewer dengue cases due to the vaccination.",
            "startOffset": 31019,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 28661,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The smallest decrease (18.8%) occurred in Mexico and the largest (26.4%) in Brazil.",
            "startOffset": 28578,
            "title": "Costs"
        },
        {
            "endOffset": 38268,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 38093,
                    "startOffset": 38089
                }
            },
            "secId": "s0065",
            "sentence": "Fifth, in line with other models included in CMDVI exercise [18], we assumed here that vaccination acts as a silent natural infection priming seronegatives to experience a secondary-like infection upon their first exposure to dengue virus.",
            "startOffset": 38029,
            "title": "Discussion"
        },
        {
            "endOffset": 39860,
            "parents": [],
            "secId": "s0065",
            "sentence": "This upward trend in incidence may make dengue vaccination increasingly cost-effective.",
            "startOffset": 39773,
            "title": "Discussion"
        },
        {
            "endOffset": 36720,
            "parents": [],
            "secId": "s0065",
            "sentence": "For areas with seroprevalence above 70%, as generally occurred in the trial sites, the models agreed well, increasing our confidence in the results.",
            "startOffset": 36572,
            "title": "Discussion"
        },
        {
            "endOffset": 36419,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 36418,
                    "startOffset": 36414
                }
            },
            "secId": "s0065",
            "sentence": "Among children aged 9 through 16 years, it averaged 78.5%, indicating that most sites satisfied the WHO criteria of seroprevalence at the vaccination age of at least 70% [19].",
            "startOffset": 36244,
            "title": "Discussion"
        },
        {
            "endOffset": 20128,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "All vaccination strategies include routine vaccination for children aged 9 years (i.e., one age cohort vaccinated annually, termed R9).",
            "startOffset": 19993,
            "title": "Overview"
        },
        {
            "endOffset": 18494,
            "parents": [],
            "secId": "s0005",
            "sentence": "Based on the findings, WHO suggested that the vaccine would generally be cost-effective and endorsed its use in locations with a dengue seroprevalence rate of 70% or higher at the proposed age of vaccination.",
            "startOffset": 18286,
            "title": "Introduction"
        },
        {
            "endOffset": 20569,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The main analysis covered a 30-year span to assess the vaccine\u2019s long-term benefit against dengue\u2019s four serotypes with 80% coverage for the first dose and low drop-out (respectively 75% and 70% coverage for the second and third dose), consistent with many routine vaccination programs.",
            "startOffset": 20283,
            "title": "Overview"
        },
        {
            "endOffset": 29178,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "On average, direct costs accounted for 21.4% and 31.5% of illness costs under a no- vaccination strategy in the Latin American and Asian countries, respectively.",
            "startOffset": 29017,
            "title": "Costs"
        },
        {
            "endOffset": 24892,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0155": {
                    "endOffset": 24891,
                    "startOffset": 24887
                }
            },
            "secId": "s0030",
            "sentence": "Here we used results of a 2016 systematic review of DALYs for a dengue episode, which considered DALYs lost during the onset, recovery and persistent-symptom phases of a dengue episode, and estimated DALYs lost at 0.032 per ambulatory case and 0.036 per hospitalized case [31].",
            "startOffset": 24615,
            "title": "Effectiveness"
        },
        {
            "endOffset": 16880,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 16693,
                    "startOffset": 16688
                },
                "b0035": {
                    "endOffset": 16693,
                    "startOffset": 16688
                }
            },
            "secId": "s0005",
            "sentence": "Under the Commission\u2019s widely used guideline [6,7], if an ICER is under one times the per capita GDP, then the intervention is highly cost-effective; an ICER between 1 and 3 times the per capita GDP makes the intervention cost effective.",
            "startOffset": 16643,
            "title": "Introduction"
        },
        {
            "endOffset": 31403,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "With the inclusion of indirect costs dengue vaccination became dominant, producing not only better health, but also cost savings in these three countries.",
            "startOffset": 31249,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 16068,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 16067,
                    "startOffset": 16064
                }
            },
            "secId": "s0005",
            "sentence": "The 3.2 million cases reported globally to the World Health Organization (WHO) in 2015, the latest data available, are 45% above those reported in 2010 [3].",
            "startOffset": 15912,
            "title": "Introduction"
        },
        {
            "endOffset": 32620,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "However, both results are lowered by about the same extent compared to 80% coverage, so the ICERs for 50% coverage (see Appendix, p10) are almost identical to those for 80% coverage.",
            "startOffset": 32438,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 37640,
            "parents": [],
            "refoffsets": {
                "b0175": {
                    "endOffset": 37639,
                    "startOffset": 37635
                }
            },
            "secId": "s0065",
            "sentence": "Third, the trials included only children up to age 14 in Asia and up to age 16 in Latin America [35].",
            "startOffset": 37539,
            "title": "Discussion"
        },
        {
            "endOffset": 34919,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 34918,
                    "startOffset": 34914
                }
            },
            "secId": "s0065",
            "sentence": "Effectiveness also tends to be high in such settings, as the vaccine is more effective on seropositive than seronegative recipients [14].",
            "startOffset": 34782,
            "title": "Discussion"
        },
        {
            "endOffset": 35475,
            "parents": [],
            "secId": "s0065",
            "sentence": "The ICERs for 10 years were higher (less favorable) than those for 30-years because the shorter horizons capture more of the costs than the benefits of investment in large scale vaccination.",
            "startOffset": 35285,
            "title": "Discussion"
        },
        {
            "endOffset": 36772,
            "parents": [],
            "secId": "s0065",
            "sentence": "Several limitations from this study should be noted.",
            "startOffset": 36720,
            "title": "Discussion"
        },
        {
            "endOffset": 34346,
            "parents": [],
            "secId": "s0065",
            "sentence": "Dengue vaccination is more favorable under the societal perspective than the health system perspective because the indirect costs of dengue illness are several times those of its direct costs.",
            "startOffset": 34154,
            "title": "Discussion"
        },
        {
            "endOffset": 21082,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "We estimated costs from both health system and societal perspectives.",
            "startOffset": 21013,
            "title": "Costs"
        },
        {
            "endOffset": 20961,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 20892,
                    "startOffset": 20888
                },
                "b0120": {
                    "endOffset": 20960,
                    "startOffset": 20953
                },
                "b0125": {
                    "endOffset": 20960,
                    "startOffset": 20953
                }
            },
            "secId": "s0020",
            "sentence": "The modeling used DenMod, a web-interface for a mathematical transmission model [22] calibrated from the two large-scale phase-3 clinical trials [24,25].",
            "startOffset": 20808,
            "title": "Overview"
        },
        {
            "endOffset": 22355,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "We estimated the time required to obtain each dengue dose to be one hour.",
            "startOffset": 22282,
            "title": "Costs"
        },
        {
            "endOffset": 30514,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Fig. 1 graphs the ICERs against per capita GDP from the health system perspective for R9C4 as an example.",
            "startOffset": 30409,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 23348,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The first step was to estimate dengue cases and deaths averted due to dengue based on the vaccine\u2019s effectiveness, using results of the two large-scale phase-3 efficacy trials.",
            "startOffset": 23172,
            "title": "Effectiveness"
        },
        {
            "endOffset": 21697,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Based on our literature review, we estimated the rate of vaccine wastage at 10% for the routine program and 5% for the catch-up program.",
            "startOffset": 21561,
            "title": "Costs"
        },
        {
            "endOffset": 30409,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "For Asia, the small average ICER of only $245 indicates that vaccination is almost cost saving.",
            "startOffset": 30314,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 34154,
            "parents": [],
            "secId": "s0065",
            "sentence": "From a societal perspective, dengue vaccination would be cost-saving in three countries, highly cost-effective in four countries, and cost-effective in the remaining three countries.",
            "startOffset": 33972,
            "title": "Discussion"
        },
        {
            "endOffset": 18652,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 18651,
                    "startOffset": 18647
                }
            },
            "secId": "s0005",
            "sentence": "WHO added that the vaccine could also be used for populations with seroprevalence between 50% and 70%, with final decisions based on site-specific data [19].",
            "startOffset": 18495,
            "title": "Introduction"
        },
        {
            "endOffset": 25491,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0140": {
                    "endOffset": 25490,
                    "startOffset": 25480
                },
                "b0165": {
                    "endOffset": 25490,
                    "startOffset": 25480
                },
                "b0170": {
                    "endOffset": 25490,
                    "startOffset": 25480
                }
            },
            "secId": "s0035",
            "sentence": "The societal perspective followed economic evaluation guidelines from Brazil and Malaysia and the US Second Panel on Cost-effectiveness Analysis [28,33,34].",
            "startOffset": 25335,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 31776,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "This comparison demonstrates that the dengue vaccine would be even more cost-effective from the societal perspective than from the health system perspective.",
            "startOffset": 31619,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 35654,
            "parents": [],
            "secId": "s0065",
            "sentence": "The results from trial sites should apply to other parts of the country where the burden of dengue is comparable or more severe, but not necessarily to those countries as a whole.",
            "startOffset": 35475,
            "title": "Discussion"
        },
        {
            "endOffset": 36243,
            "parents": [],
            "secId": "s0065",
            "sentence": "Across all trial sites, the baseline seroprevalence at ages 9 through 12 years ranged from 48.3% to 88.5%.",
            "startOffset": 36137,
            "title": "Discussion"
        },
        {
            "endOffset": 32053,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The threshold analyses show that the highest prices per vaccine dose at which vaccination remains cost-effective would range from $32.96 and $41.40 in Honduras to $326.60 and $441.35 in Puerto Rico from health system and societal perspectives, respectively (see Appendix, p15).",
            "startOffset": 31776,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 27707,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Over the first 10 years following vaccine introduction, the additional cohorts (R9C4 and R9C8) of catch-up vaccination generated further reductions in mortality beyond R9 of 8.7% and 15.7% in the Latin American countries, and of 7.4% and 13.4% in the Asian countries, respectively (see Appendix, p12).",
            "startOffset": 27406,
            "title": "Effectiveness"
        },
        {
            "endOffset": 24017,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The mathematical model used in this analysis is an age-structured, host-vector, serotype-specific compartmental model that includes seasonality and accounts for the transmission dynamics of the four dengue serotypes in humans and mosquitoes at the population level.",
            "startOffset": 23752,
            "title": "Effectiveness"
        },
        {
            "endOffset": 22096,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 22095,
                    "startOffset": 22091
                }
            },
            "secId": "s0025",
            "sentence": "We estimated the indirect cost of premature death using a human capital approach [29].",
            "startOffset": 22010,
            "title": "Costs"
        },
        {
            "endOffset": 19445,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 19341,
                    "startOffset": 19337
                },
                "b0110": {
                    "endOffset": 19394,
                    "startOffset": 19390
                },
                "b0115": {
                    "endOffset": 19444,
                    "startOffset": 19440
                }
            },
            "secId": "s0005",
            "sentence": "This study uses detailed three-year trial results from the countries [14], a model of dengue transmission and vaccination [22], and estimates of economic burden by country [23].",
            "startOffset": 19268,
            "title": "Introduction"
        },
        {
            "endOffset": 33431,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The scenarios for a 10-year time horizon with 80% coverage under R9 (see Appendix, pp12\u201314) showed that the averted DALYs per person per year were lower than those assessed over 30 years for Latin America (18% lower) and Asia (20% lower), with lower averted disease costs per person per year (18% lower in Latin America and 22% in Asia).",
            "startOffset": 33094,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 25334,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "We derived ICERs for the three vaccination strategies from both health system and societal perspectives.",
            "startOffset": 25230,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 19203,
            "parents": [],
            "secId": "s0005",
            "sentence": "This paper develops empirical cost-effectiveness analyses to inform decision making in the 10 endemic phase-3 \u201ccountries.\u201d",
            "startOffset": 19081,
            "title": "Introduction"
        },
        {
            "endOffset": 28577,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Under R9, for example, the disease costs per capita dropped on average by 22.2% ($2.34) in the five Latin American countries, from $10.51 to $8.17 per capita.",
            "startOffset": 28419,
            "title": "Costs"
        },
        {
            "endOffset": 23106,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0150": {
                    "endOffset": 23105,
                    "startOffset": 23101
                }
            },
            "secId": "s0030",
            "sentence": "We expressed effectiveness in DALYs, which account both for years of life lost due to disability and years of life lost due to premature death [30].",
            "startOffset": 22958,
            "title": "Effectiveness"
        },
        {
            "endOffset": 38028,
            "parents": [],
            "refoffsets": {
                "b0195": {
                    "endOffset": 37999,
                    "startOffset": 37995
                }
            },
            "secId": "s0065",
            "sentence": "Earlier models have suggested potential beneficial synergies under intensive transmission [39], but further work is needed.",
            "startOffset": 37905,
            "title": "Discussion"
        },
        {
            "endOffset": 32293,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The corresponding highest prices for which vaccination would remain highly cost-effective (a more demanding standard) would be lower: \u2212$11.05 and $19.61 for Vietnam, and $120.93 and $235.68 in Puerto Rico, respectively (see Appendix, p16).",
            "startOffset": 32054,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 32775,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Using regional averages for R9C4 as an example, 50% coverage achieves 63% of the DALY reduction in Latin America and 62% in Asia compared to 80% coverage.",
            "startOffset": 32621,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 34530,
            "parents": [],
            "secId": "s0065",
            "sentence": "With the lowest share of cases hospitalized among the ten countries, its direct costs are relatively low.",
            "startOffset": 34425,
            "title": "Discussion"
        },
        {
            "endOffset": 17594,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 17593,
                    "startOffset": 17589
                }
            },
            "secId": "s0005",
            "sentence": "A 2015 pooled analysis of results of randomized trials of the vaccine across 10 countries in the Americas and Asia reported that the efficacy against virologically-confirmed dengue illness in the 25 months post-dose 1 was 60.3% (95% confidence interval [CI]: 55.7\u201364.5%) for all participants (aged 2 through 16 years) and 65.6% (95% CI: 60.7\u201369.9%) for subjects aged 9 and above [14].",
            "startOffset": 17210,
            "title": "Introduction"
        },
        {
            "endOffset": 40344,
            "parents": [],
            "secId": "s0075",
            "sentence": "DS and LC conceptualized the study.",
            "startOffset": 40309,
            "title": "Contributions"
        },
        {
            "endOffset": 35112,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 35111,
                    "startOffset": 35107
                }
            },
            "secId": "s0065",
            "sentence": "High costs per case of dengue illness are generally linked with a high per capita GDP, as the costs of medical care and the productivity loss from illness are roughly proportional to GDP [23].",
            "startOffset": 34920,
            "title": "Discussion"
        },
        {
            "endOffset": 25209,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0160": {
                    "endOffset": 25107,
                    "startOffset": 25103
                }
            },
            "secId": "s0030",
            "sentence": "The mathematical model, with equations and input data described elsewhere [32], projected the impact of various vaccination strategies in the areas where the trials were conducted.",
            "startOffset": 25029,
            "title": "Effectiveness"
        },
        {
            "endOffset": 25969,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Sensitivity analyses explored uncertainty in key parameters: vaccine efficacy, vaccine administration cost, treatment cost per episode, vaccine wastage, case-fatality rate, and compliance with vaccination (see Appendix, p7).",
            "startOffset": 25745,
            "title": "Sensitivity analysis"
        },
        {
            "endOffset": 39377,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 39220,
                    "startOffset": 39216
                },
                "b0185": {
                    "endOffset": 39376,
                    "startOffset": 39372
                }
            },
            "secId": "s0065",
            "sentence": "Our focus is consistent with WHO\u2019s recommendations on the use of dengue vaccination [19] and seeks to avoid potential risks of increased hospitalization if younger children or cohorts with substantially lower seroprevalence were vaccinated [37].",
            "startOffset": 39132,
            "title": "Discussion"
        },
        {
            "endOffset": 23172,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "We calculated DALYs averted due to vaccination using three steps.",
            "startOffset": 23107,
            "title": "Effectiveness"
        },
        {
            "endOffset": 37100,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 37099,
                    "startOffset": 37095
                }
            },
            "secId": "s0065",
            "sentence": "The vaccine has, however, proved effective in reducing not only symptomatic, but also asymptomatic dengue infections [38].",
            "startOffset": 36978,
            "title": "Discussion"
        },
        {
            "endOffset": 16191,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 16190,
                    "startOffset": 16187
                },
                "b0020": {
                    "endOffset": 16172,
                    "startOffset": 16169
                }
            },
            "secId": "s0005",
            "sentence": "Including unreported cases, the estimated number of symptomatic dengue cases ranged from 58,400,000 [4] to 96,000,000 [1].",
            "startOffset": 16069,
            "title": "Introduction"
        },
        {
            "endOffset": 25028,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The third step was to combine the estimates from the previous steps and deaths due to dengue to generate DALYs averted from vaccination.",
            "startOffset": 24892,
            "title": "Effectiveness"
        },
        {
            "endOffset": 28897,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "In the Asian countries, the percentage reductions ranged from 21.5% in Indonesia to 23.8% in Vietnam.",
            "startOffset": 28796,
            "title": "Costs"
        },
        {
            "endOffset": 16310,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 16309,
                    "startOffset": 16306
                }
            },
            "secId": "s0005",
            "sentence": "A dengue vaccine has engaged policy makers since 1993 as a potentially cost-effective strategy for dengue control [5].",
            "startOffset": 16192,
            "title": "Introduction"
        },
        {
            "endOffset": 39772,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 39771,
                    "startOffset": 39768
                }
            },
            "secId": "s0065",
            "sentence": "As noted earlier, despite substantial year-to-year fluctuation, the number of cases reported to the World Health Organization has actually been increasing rapidly in recent years due to increasing urbanization, travel, and other factors [3].",
            "startOffset": 39531,
            "title": "Discussion"
        },
        {
            "endOffset": 18115,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 18114,
                    "startOffset": 18101
                },
                "b0060": {
                    "endOffset": 18114,
                    "startOffset": 18101
                },
                "b0080": {
                    "endOffset": 18114,
                    "startOffset": 18101
                },
                "b0085": {
                    "endOffset": 18114,
                    "startOffset": 18101
                }
            },
            "secId": "s0005",
            "sentence": "Projections for Brazil, the Philippines and Mexico suggested that dengue vaccination would be cost-effective from a societal perspective provided the cost per vaccine dose in these countries remained below US$77, US$262, and US$214, respectively [11,12,16,17].",
            "startOffset": 17855,
            "title": "Introduction"
        },
        {
            "endOffset": 30017,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "In the five Asian countries, the average ICER was $3751/DALY averted, with a range of $1935/DALY in Malaysia to $5101/DALY averted in the Philippines.",
            "startOffset": 29867,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 31618,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "In four other countries (Colombia, Indonesia, Mexico, and Thailand) the strategy would be highly cost effective, and in the three remaining countries (Honduras, Philippines, and Vietnam) it would be cost effective.",
            "startOffset": 31404,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 25744,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "All results presented in this paper are based on 1000 Monte Carlo simulations, generating both averages and 95% CIs.",
            "startOffset": 25628,
            "title": "Sensitivity analysis"
        },
        {
            "endOffset": 26655,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Country-specific results showed reductions in the incidence ranging from 21.4% in Puerto Rico to 25.6% in Brazil among the Latin American countries and from 19.9% in Indonesia to 23.9% in Malaysia in the Asian countries.",
            "startOffset": 26435,
            "title": "Effectiveness"
        },
        {
            "endOffset": 33701,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Under R9C4, annual vaccination costs and ICERs for the 10-year time horizon were higher (less favorable) with $5726/DALY for Latin America and $4020/DALY Asia; these are 36% and 7% above corresponding 30-year ICERs for the health system perspective (see Appendix, p14).",
            "startOffset": 33432,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 37806,
            "parents": [],
            "secId": "s0065",
            "sentence": "Trial data suggested that the benefits of vaccination rose with age at vaccination over this range, but benefits in older recipients have not been assessed directly.",
            "startOffset": 37641,
            "title": "Discussion"
        },
        {
            "endOffset": 21012,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "All costs are expressed in 2015 US dollars.",
            "startOffset": 20969,
            "title": "Costs"
        },
        {
            "endOffset": 40505,
            "parents": [],
            "secId": "s0075",
            "sentence": "All authors participated in the data analyses and interpretation, helped to draft and critically revise the manuscript and approved the final version submitted.",
            "startOffset": 40345,
            "title": "Contributions"
        },
        {
            "endOffset": 16989,
            "parents": [],
            "secId": "s0005",
            "sentence": "A literature review identified 32 publications with economic analyses of a dengue vaccine (see Appendix, p1).",
            "startOffset": 16880,
            "title": "Introduction"
        },
        {
            "endOffset": 18285,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 18284,
                    "startOffset": 18280
                }
            },
            "secId": "s0005",
            "sentence": "In 2015, WHO organized the Comparative Modeling of Dengue Vaccine Impact (CMDVI) exercise comparing eight mathematical models, including the one used in this study [18].",
            "startOffset": 18116,
            "title": "Introduction"
        },
        {
            "endOffset": 26067,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Threshold analyses calculated the maximum vaccine price for vaccination to remain cost-effective.",
            "startOffset": 25970,
            "title": "Sensitivity analysis"
        },
        {
            "endOffset": 17855,
            "parents": [],
            "refoffsets": {
                "b0075": {
                    "endOffset": 17854,
                    "startOffset": 17850
                }
            },
            "secId": "s0005",
            "sentence": "The five-year follow-up for subjects aged 9 and above (the age group for which the vaccine was subsequently licensed) showed the vaccine efficacy remained high against hospitalized dengue in both Asia (55%, CI: 33\u201370%) and Latin America (68%, CI: 52\u201378%) [15].",
            "startOffset": 17595,
            "title": "Introduction"
        },
        {
            "endOffset": 29642,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Table 4 shows the ICERs and their 95% CIs of the three dengue vaccination strategies under the two perspectives.",
            "startOffset": 29530,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 30811,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Comparisons to the thresholds of 1 time and 3 times GDP per capita show that dengue vaccination would be highly cost-effective in all countries except three (Honduras, Philippines, and Vietnam,), and at least cost effective in all 10 countries from the health system (public payer\u2019s) perspective.",
            "startOffset": 30515,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 24614,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Although DALYs for dengue were reported in the Global Burden of Diseases (GBD) study, GBD estimates used a generic infectious disease, not specifically dengue.",
            "startOffset": 24455,
            "title": "Effectiveness"
        },
        {
            "endOffset": 35877,
            "parents": [],
            "refoffsets": {
                "b0175": {
                    "endOffset": 35876,
                    "startOffset": 35872
                }
            },
            "secId": "s0065",
            "sentence": "Comparisons of trial results with active surveillance against routine reporting with passive surveillance indicated that the trial sites had substantially higher dengue incidence than the respective national averages [35].",
            "startOffset": 35655,
            "title": "Discussion"
        },
        {
            "endOffset": 37904,
            "parents": [],
            "secId": "s0065",
            "sentence": "Fourth, the combined application of vaccination and vector control remains an important question.",
            "startOffset": 37807,
            "title": "Discussion"
        },
        {
            "endOffset": 22613,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The shortest would be a few minutes for an extra service at an existing clinical visit or school-based program, the initial strategy in Manila, the Philippines.",
            "startOffset": 22453,
            "title": "Costs"
        },
        {
            "endOffset": 39530,
            "parents": [],
            "secId": "s0065",
            "sentence": "The study was conservative in that it assumed that the incidence of dengue observed during the trial would continue over the 30-year period of the model.",
            "startOffset": 39377,
            "title": "Discussion"
        },
        {
            "endOffset": 24390,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "It incorporates multiple types of serotype interactions: temporary cross-protection (i.e., no risk of developing a heterotypic infection for a limited time after an infection), cross-enhancement (i.e., differential risk of developing symptomatic cases upon primary, secondary, tertiary and quaternary infection), or a combination of cross-protection and cross-enhancement.",
            "startOffset": 24018,
            "title": "Effectiveness"
        },
        {
            "endOffset": 28795,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "In the five Asian countries, the reduction of disease costs averaged 23.2% ($1.34) under R9, dropping from $5.78 to $4.44 per capita.",
            "startOffset": 28662,
            "title": "Costs"
        },
        {
            "endOffset": 20807,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 20806,
                    "startOffset": 20799
                },
                "b0135": {
                    "endOffset": 20806,
                    "startOffset": 20799
                }
            },
            "secId": "s0020",
            "sentence": "In each case we compared the vaccination strategies against the status quo (no vaccine) using a standard cost-effectiveness framework [26,27].",
            "startOffset": 20665,
            "title": "Overview"
        },
        {
            "endOffset": 29509,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The shares did not vary much under the different vaccine strategies within each country; they did, however, vary substantially across countries.",
            "startOffset": 29365,
            "title": "Costs"
        },
        {
            "endOffset": 34714,
            "parents": [],
            "secId": "s0065",
            "sentence": "Three factors tend to make dengue vaccination particularly cost-effective (or even cost saving) in a country: high incidence of dengue, high vaccination impact, and high cost per case.",
            "startOffset": 34530,
            "title": "Discussion"
        },
        {
            "endOffset": 20664,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Alternative scenarios explored lower (i.e. 50%) coverage and a shorter (10-year) time horizon.",
            "startOffset": 20570,
            "title": "Overview"
        },
        {
            "endOffset": 27405,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The reduction in mortality ranged from 17.3% (Mexico) to 27.0% (Brazil) among the Latin American countries and from 22.1% (Indonesia) to 25.4% (Thailand) in the Asian countries.",
            "startOffset": 27228,
            "title": "Effectiveness"
        },
        {
            "endOffset": 28075,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The model estimated that under R9, on average, 18.55 and 24.53 DALYs per 100,000 population were averted annually in the five Latin American and Asian countries, respectively.",
            "startOffset": 27900,
            "title": "Effectiveness"
        },
        {
            "endOffset": 32437,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Under the scenario of 50% coverage (see Appendix, pp8\u20139), both effectiveness and costs are lower than the corresponding values for 80% coverage.",
            "startOffset": 32293,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 27900,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Over 30 years the additional benefits generated by catch-up campaigns are less visible (Table 2), as the average annual numbers of cases and deaths for R9C4 and R9C8 are close to those for R9.",
            "startOffset": 27708,
            "title": "Effectiveness"
        },
        {
            "endOffset": 21300,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Our base estimate assumed a sales price of $20 per dose, close to that of the Philippines program.",
            "startOffset": 21202,
            "title": "Costs"
        },
        {
            "endOffset": 27227,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The corresponding reduction in the five Asian countries also averaged 23.7%, falling from 2.71 to 2.07 per 100,000 population.",
            "startOffset": 27101,
            "title": "Effectiveness"
        },
        {
            "endOffset": 32916,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "These percentages are almost identical to the ratio of 63% (i.e. 50%/80%) expected if the DALY gains were directly proportional to coverage.",
            "startOffset": 32776,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 24454,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The second step was to obtain the DALYs lost per dengue episode.",
            "startOffset": 24390,
            "title": "Effectiveness"
        },
        {
            "endOffset": 29364,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 29363,
                    "startOffset": 29359
                }
            },
            "secId": "s0055",
            "sentence": "The share of direct disease costs was particularly low in Brazil, given its relatively high costs due to the loss of productivity for both hospitalized and ambulatory dengue cases [23].",
            "startOffset": 29179,
            "title": "Costs"
        },
        {
            "endOffset": 22906,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Table 1 provides vaccine delivery, treatment, and indirect costs, as well as GDP per capita and dengue case fatality rates.",
            "startOffset": 22783,
            "title": "Costs"
        },
        {
            "endOffset": 33971,
            "parents": [],
            "secId": "s0065",
            "sentence": "Using the criteria from WHO\u2019s Commission on Macroeconomics and Health, our study shows that from the health system perspective, routine dengue vaccination would be at least cost-effective in all 10 countries, and highly cost-effective in seven of these sites.",
            "startOffset": 33712,
            "title": "Discussion"
        },
        {
            "endOffset": 26938,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Over 30 years, when compared to R9 alone, the additional cohorts (R9C4 and R9C8) of catch-up vaccination generated further reductions in the incidence of dengue of 11.6% and 20.8% in the Latin American countries, and of 9.9% and 17.4% in the Asian countries, respectively (Table 2).",
            "startOffset": 26656,
            "title": "Effectiveness"
        },
        {
            "endOffset": 18757,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 18756,
                    "startOffset": 18752
                }
            },
            "secId": "s0005",
            "sentence": "Following licensure, both Brazil and the Philippines initiated sub-national public sector programs [20].",
            "startOffset": 18653,
            "title": "Introduction"
        },
        {
            "endOffset": 36136,
            "parents": [],
            "refoffsets": {
                "b0180": {
                    "endOffset": 36135,
                    "startOffset": 36131
                }
            },
            "secId": "s0065",
            "sentence": "For example, active surveillance at trial sites in Brazil, Colombia, and Mexico had 25 times the expected rate of cases compared to passive surveillance based on national data, but only 10 times the expected rate derived from local passive surveillance [36].",
            "startOffset": 35878,
            "title": "Discussion"
        },
        {
            "endOffset": 19866,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Five countries are in Southeast Asia (Indonesia, Malaysia, Philippines, Thailand, and Vietnam) and five in Latin America (Brazil, Colombia, Honduras, Mexico, and Puerto Rico).",
            "startOffset": 19691,
            "title": "Overview"
        },
        {
            "endOffset": 22782,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The longest would entail a separate trip for a clinical visit exclusively for dengue vaccination, consistent with the community-based strategy in Brazil\u2019s Parana state.",
            "startOffset": 22614,
            "title": "Costs"
        },
        {
            "endOffset": 19081,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 19080,
                    "startOffset": 19076
                }
            },
            "secId": "s0005",
            "sentence": "As of October 13, 2017, 19 countries had registered the Sanofi Pasteur (France) vaccine: Argentina, Bolivia, Brazil, El Salvador, Costa Rica, Guatemala, Honduras, Mexico, Paraguay, Peru, and Venezuela in Latin America, and Australia, Bangladesh, Cambodia, Indonesia, Malaysia, Philippines, Singapore, Thailand in Asia [21].",
            "startOffset": 18758,
            "title": "Introduction"
        },
        {
            "endOffset": 22452,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "This value reflects the breadth of potential delivery strategies with varying time requirements.",
            "startOffset": 22356,
            "title": "Costs"
        },
        {
            "endOffset": 33094,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Specifically, the ICERs for 50% coverage ($4101 for Latin America and $3868 for Asia) are within 4% of the corresponding values for 80% coverage ($4207 and $3737, respectively).",
            "startOffset": 32917,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 29866,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "From the health system perspective, under R9 in the five Latin American countries the average ICER was $4216/DALY averted, ranging from $666 in Puerto Rico (most favorable) to $5865/DALY averted in Mexico (least favorable).",
            "startOffset": 29643,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 35284,
            "parents": [],
            "secId": "s0065",
            "sentence": "The various scenarios considered found that cost-effectiveness was relatively insensitive to the variation in coverage rate or the number of catch-up cohorts over 30 years.",
            "startOffset": 35112,
            "title": "Discussion"
        },
        {
            "endOffset": 34424,
            "parents": [],
            "secId": "s0065",
            "sentence": "This is particularly prominent in Brazil, where productivity losses are high.",
            "startOffset": 34347,
            "title": "Discussion"
        },
        {
            "endOffset": 29016,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The direct costs from the treatment of dengue for inpatients and outpatients were much smaller than the indirect costs.",
            "startOffset": 28897,
            "title": "Costs"
        },
        {
            "endOffset": 36977,
            "parents": [],
            "secId": "s0065",
            "sentence": "First, while the clinical trial provides considerable data on the efficacy of dengue vaccine in recipients, it does not provide direct data on the magnitude of the herd effect against dengue transmission.",
            "startOffset": 36773,
            "title": "Discussion"
        },
        {
            "endOffset": 22009,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0140": {
                    "endOffset": 22008,
                    "startOffset": 22004
                }
            },
            "secId": "s0025",
            "sentence": "The societal perspective added the indirect costs of illness and premature death, and opportunity costs of time required to obtain each dengue dose [28].",
            "startOffset": 21856,
            "title": "Costs"
        },
        {
            "endOffset": 22942,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "For more details, see Appendix, p2.",
            "startOffset": 22907,
            "title": "Costs"
        },
        {
            "endOffset": 38515,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 38397,
                    "startOffset": 38393
                }
            },
            "secId": "s0065",
            "sentence": "This assumption helps explain the possible adverse effects of vaccination in young recipients that were mostly seronegative [19] although this hypothesis still needs to be examined by additional information on the long-term impact of vaccination.",
            "startOffset": 38269,
            "title": "Discussion"
        },
        {
            "endOffset": 38903,
            "parents": [],
            "refoffsets": {
                "b0200": {
                    "endOffset": 38840,
                    "startOffset": 38836
                }
            },
            "secId": "s0065",
            "sentence": "Finally, while contextual factors and affordability also affect program implementation [40], they were outside the scope of this cost-effectiveness study.",
            "startOffset": 38749,
            "title": "Discussion"
        },
        {
            "endOffset": 40050,
            "parents": [],
            "secId": "s0070",
            "sentence": "Authors WZ, YH-R, DS declare that they had no financial interests in the vaccine or manufacturer, but received funding to undertake the study through their university.",
            "startOffset": 39883,
            "title": "Declaration of interest"
        },
        {
            "endOffset": 22281,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "To reflect the diverse ages of dengue fatalities, we estimated this indirect cost as the product of GDP per capita times the number of discounted life years lost due to a dengue death.",
            "startOffset": 22097,
            "title": "Costs"
        },
        {
            "endOffset": 34781,
            "parents": [],
            "secId": "s0065",
            "sentence": "In high incidence areas, the seroprevalence rate tends to be high.",
            "startOffset": 34715,
            "title": "Discussion"
        },
        {
            "endOffset": 30313,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Under the societal perspective, the average ICER for Latin America is negative (\u2212$5474) indicating that vaccination is cost saving.",
            "startOffset": 30182,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 26434,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "In the five Asian countries this strategy lowered the incidence of dengue by 21.6% on average (from 1297 by 281 per 100,000 population).",
            "startOffset": 26298,
            "title": "Effectiveness"
        },
        {
            "endOffset": 25605,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0030": {
                    "endOffset": 25567,
                    "startOffset": 25564
                }
            },
            "secId": "s0035",
            "sentence": "We interpreted ICERs using the WHO Macroeconomics and Health Guidelines [6] of 1 time and 3 times per capita GDP.",
            "startOffset": 25492,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 36571,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 36527,
                    "startOffset": 36523
                },
                "b0185": {
                    "endOffset": 36570,
                    "startOffset": 36566
                }
            },
            "secId": "s0065",
            "sentence": "The model used here was compared with results obtained with other models involved in the CMDVI exercise [18], including one published individually [37].",
            "startOffset": 36419,
            "title": "Discussion"
        },
        {
            "endOffset": 37538,
            "parents": [],
            "secId": "s0065",
            "sentence": "However, uncertainties remain and post-licensure studies are expected to play a critical role to better inform the evolution of vaccine benefits over time.",
            "startOffset": 37383,
            "title": "Discussion"
        },
        {
            "endOffset": 38748,
            "parents": [],
            "refoffsets": {
                "b0140": {
                    "endOffset": 38747,
                    "startOffset": 38743
                }
            },
            "secId": "s0065",
            "sentence": "Sixth, although we used the guidelines from WHO\u2019s Commission on Macroeconomics and Health for comparability with prior studies, the Second Panel on Cost-effectiveness in Health does not recommend a specific threshold for ICERs [28].",
            "startOffset": 38516,
            "title": "Discussion"
        },
        {
            "endOffset": 40103,
            "parents": [],
            "secId": "s0070",
            "sentence": "DS also received travel funding from Sanofi Pasteur.",
            "startOffset": 40051,
            "title": "Declaration of interest"
        },
        {
            "endOffset": 20283,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Two optional catch-up campaigns were also examined, consisting of 4 or 8 age cohorts, and reaching the target coverage over 2 years, termed R9C4 and R9C8.",
            "startOffset": 20129,
            "title": "Overview"
        },
        {
            "endOffset": 30181,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The ICERs for strategies with catch-up cohorts were generally similar to those for routine programs alone, with no consistent patterns among the small differences.",
            "startOffset": 30018,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 21201,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The health system perspective incorporated costs of vaccine purchase, vaccine delivery, and treatment of dengue cases.",
            "startOffset": 21083,
            "title": "Costs"
        },
        {
            "endOffset": 15911,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 15910,
                    "startOffset": 15905
                },
                "b0010": {
                    "endOffset": 15910,
                    "startOffset": 15905
                }
            },
            "secId": "s0005",
            "sentence": "Dengue, one of the world\u2019s most health threatening vector-borne viral diseases, is rapidly spreading to latitudes with little previous transmission and now places half the world\u2019s population at risk [1,2].",
            "startOffset": 15706,
            "title": "Introduction"
        },
        {
            "endOffset": 23535,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "These were conducted in five Latin American countries on children aged at the start of follow-up between 9 and 16 years, and five Asian countries on children aged between 2 and 14 years.",
            "startOffset": 23349,
            "title": "Effectiveness"
        },
        {
            "endOffset": 40296,
            "parents": [],
            "secId": "s0070",
            "sentence": "All authors discussed data analyses and interpretation, helped to draft and critically revise the manuscript and approved the final version submitted.",
            "startOffset": 40146,
            "title": "Declaration of interest"
        },
        {
            "endOffset": 17209,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 17208,
                    "startOffset": 17200
                },
                "b0040": {
                    "endOffset": 17208,
                    "startOffset": 17200
                },
                "b0045": {
                    "endOffset": 17208,
                    "startOffset": 17200
                },
                "b0050": {
                    "endOffset": 17208,
                    "startOffset": 17200
                },
                "b0055": {
                    "endOffset": 17208,
                    "startOffset": 17200
                },
                "b0060": {
                    "endOffset": 17208,
                    "startOffset": 17200
                },
                "b0065": {
                    "endOffset": 17208,
                    "startOffset": 17200
                }
            },
            "secId": "s0005",
            "sentence": "Seven studies from 2013 through 2017, based on assumed or phase-2B efficacy data of a recombinant, live attenuated tetravalent dengue vaccine indicated that such a dengue vaccine would likely be cost effective [5,8\u201313].",
            "startOffset": 16990,
            "title": "Introduction"
        },
        {
            "endOffset": 27100,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Similarly, R9 reduced the mortality rate of dengue by an average of 23.7% in the five Latin American countries, dropping from 1.92 to 1.47 per 100,000 population.",
            "startOffset": 26938,
            "title": "Effectiveness"
        },
        {
            "endOffset": 28305,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The catch-up cohorts (R9C4 and R9C8) averted an additional 2.17 and 3.86 DALYs per 100,000 population in the five Latin American countries, and 2.43 and 4.22 DALYs per 100,000 population in the five Asian countries, respectively.",
            "startOffset": 28076,
            "title": "Effectiveness"
        },
        {
            "endOffset": 30910,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Graphically, all 10 countries\u2019 points fall below the line of three times GDP per capita or better.",
            "startOffset": 30812,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 31018,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Fig. 2 shows the ICERs from the societal perspective with the indirect costs included for the same strategy.",
            "startOffset": 30910,
            "title": "Cost-effectiveness"
        },
        {
            "endOffset": 37382,
            "parents": [],
            "refoffsets": {
                "b0110": {
                    "endOffset": 37187,
                    "startOffset": 37183
                }
            },
            "secId": "s0065",
            "sentence": "Second, the present analysis accounts for most factors impacting vaccine efficacy [22] (serotype, serostatus at baseline, severity, number of doses received, waning of vaccine protection over time) as well as the potential impact of vaccination on infectivity and disease dynamics.",
            "startOffset": 37101,
            "title": "Discussion"
        },
        {
            "endOffset": 19267,
            "parents": [],
            "secId": "s0005",
            "sentence": "Hereafter, we treat Puerto Rico as a \u201ccountry\u201d for convenience.",
            "startOffset": 19204,
            "title": "Introduction"
        },
        {
            "endOffset": 16642,
            "parents": [],
            "secId": "s0005",
            "sentence": "The WHO\u2019s Commission on Macroeconomics and Health suggested that the cost-effectiveness of a health intervention could be judged by comparing its incremental cost-effectiveness ratio (ICER) per disability-adjusted life year (DALY) averted to the per capita gross domestic product (GDP) of the country or region considering its use.",
            "startOffset": 16311,
            "title": "Introduction"
        },
        {
            "endOffset": 21856,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "We obtained the direct treatment cost of dengue cases and associated indirect costs by setting (e.g. hospital cases and ambulatory cases) from the literature.",
            "startOffset": 21698,
            "title": "Costs"
        },
        {
            "endOffset": 23751,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "These trial data were used to estimate the main parameters of a transmission model: efficacy and duration of protection by age and serostatus at vaccination, transmission intensity, and interactions among serotypes.",
            "startOffset": 23536,
            "title": "Effectiveness"
        },
        {
            "endOffset": 40145,
            "parents": [],
            "secId": "s0070",
            "sentence": "NB and LC are employed by Sanofi Pasteur.",
            "startOffset": 40104,
            "title": "Declaration of interest"
        },
        {
            "endOffset": 21560,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "We derived the vaccine delivery cost from literature covering the cost of vaccine delivery in non-campaign settings (i.e., health facility-based approach, outreach, and school-based approach) and adjusted to countries\u2019 GDP per capita using a regression model.",
            "startOffset": 21301,
            "title": "Costs"
        },
        {
            "endOffset": 39131,
            "parents": [],
            "secId": "s0065",
            "sentence": "The analysis considered only strategies consistent with the vaccine\u2019s licensure (age 9 and above) and sites with epidemiology based on the trial sites (e.g. seroprevalence at vaccination of 78.5% among children aged 9\u201316 years).",
            "startOffset": 38903,
            "title": "Discussion"
        },
        {
            "endOffset": 19992,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 19991,
                    "startOffset": 19984
                },
                "b0125": {
                    "endOffset": 19991,
                    "startOffset": 19984
                }
            },
            "secId": "s0020",
            "sentence": "The vaccination schedule consists of three injections administered at six-month intervals used in the phase-3 trials [24,25].",
            "startOffset": 19867,
            "title": "Overview"
        }
    ],
    "docId": "S0264410X17316638",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Wu",
                "initial": "W.",
                "last": "Zeng"
            },
            {
                "email": null,
                "first": "Yara A.",
                "initial": "Y.A.",
                "last": "Halasa-Rappel"
            },
            {
                "email": null,
                "first": "Nicolas",
                "initial": "N.",
                "last": "Baurin"
            },
            {
                "email": null,
                "first": "Laurent",
                "initial": "L.",
                "last": "Coudeville"
            },
            {
                "email": "shepard@brandeis.edu",
                "first": "Donald S.",
                "initial": "D.S.",
                "last": "Shepard"
            }
        ],
        "doi": "10.1016/j.vaccine.2017.11.064",
        "firstpage": "413",
        "issn": "0264410X",
        "lastpage": "420",
        "openaccess": "Full",
        "pub_year": 2018,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Cost-effectiveness of dengue vaccination in ten endemic countries"
    }
}